查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1833579

2032 年整形外科植入市场预测：按产品类型、生物材料、手术程序、设备类型、最终用户和地区进行的全球分析

Orthopedic Implants Market Forecasts to 2032 - Global Analysis By Product Type, Biomaterial, Procedure, Device Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球整形外科植入市场预计在 2025 年达到 559.2 亿美元，到 2032 年将达到 863.3 亿美元，预测期内的复合年增长率为 6.4%。

整形外科植入是医疗设备，旨在透过替换、稳定或加强受损的骨骼结构来帮助修復骨骼和关节。这些植入通常由耐用且生物相容性的材料製成，例如钛、不銹钢或陶瓷，可安全用于人体。它们常用于整形外科手术，以治疗骨折、关节炎和退化性骨病。透过恢復结构完整性和运动功能，它们可以显着减轻不适，并增强患者的功能健康和幸福感。

根据世界卫生组织 (WHO) 2022 年的数据，全球有 17.1 亿人患有肌肉骨骼疾病，包括背痛、颈部、骨折、其他损伤、骨关节炎、类风湿性关节炎和类风湿性关节炎。

老年人口不断增加

骨质疏鬆症、关节炎和关节退化等疾病在老年人中日益普遍，需要手术介入。医疗保健系统越来越多地采用先进的植入技术，以改善老年患者的活动能力和生活品质。微创整形外科手术日益普及，缩短了復原时间和住院时间。植入设计和生物材料的创新正在改善植入物的贴合度和长期疗效。随着全球预期寿命的延长，整形外科植入市场可望持续扩张。

熟练骨科医生短缺

训练有素的骨科医生短缺阻碍了整形外科植入领域的发展。许多地区，尤其是新兴国家，在专业外科手术方面面临巨大的人才缺口。植入手术的复杂性需要严格的训练和经验积累，导致合格人员数量有限。监管要求和认证流程进一步阻碍了新外科医生进入该领域。这种人才缺口导致手术延误和患者预后不佳。如果不对医学教育和培训进行策略性投资，市场成长可能会受到限制。

门诊手术中心（ASC）的兴起

日间手术中心正成为整形外科植入市场的成长引擎。这些设施为在传统医院外进行整形外科手术提供了经济高效的环境。日间手术中心配备的先进影像处理和手术技术日益增多，能够加快复杂植入手术的患者周转速度。优惠的报销政策和更短的恢復时间正吸引患者和医疗服务提供者来到这些中心。门诊病人护理的趋势正在加速对便携式模组化植入系统的需求。随着医疗保健的去中心化，日间手术中心正成为整形外科创新和服务交付的重要枢纽。

定价压力和报销问题

政府和保险公司正在加强成本控制，迫使製造商降低价格。报销延迟和政策变化扰乱了现金流，阻碍了产品的普及。高昂的开发和合规成本使得公司难以在这种环境下保持盈利。规模较小的公司尤其容易受到价格波动和报销不确定性。这些财务压力可能会减缓创新，并限制先进植入技术的普及。

COVID-19的影响：

新冠疫情扰乱了整形外科植入手术，推迟了择期手术，并导致医院资源紧张。封锁和供应链中断导致植入零件和手术器械短缺。然而，这场危机加速了数位化应用，远距会诊和远距復健变得越来越流行。监管机构推出了快速核准，以确保患者能够持续获得必要的整形外科设备。疫情后的策略如今强调韧性、自动化和本地製造，以减轻未来的干扰。市场正在适应变化，重新整体整形外科护理的灵活性和数位化整合。

金属生物材料领域预计将成为预测期内最大的领域

预计金属生物材料领域将在预测期内占据最大的市场份额。这些材料，包括钛和不銹钢，在承重应用中具有卓越的强度、生物相容性和耐久性。它们在人工关节、脊椎移植和创伤固定装置中的广泛应用，推动了其市场主导。表面涂层和合金成分的不断进步，正在改善其与骨组织的整合。医院和外科中心因其可靠性和长期性能而更青睐金属植入。随着整形外科手术需求的不断增长，金属生物材料很可能将继续在植入创新中发挥关键作用。

预计门诊手术中心部分在预测期内的复合年增长率最高

预计门诊手术中心细分市场将在预测期内达到最高成长率。门诊手术中心 (ASC) 能够以低成本提供优质护理，正在重塑外科手术格局。 ASC 越来越多地使用先进的植入系统进行关节重建和骨折修復。营运效率的提高和良好的保险覆盖范围正在推动患者对这些设施的偏好。数位库存和云端基础监控的整合正在简化植入管理。随着门诊整形外科护理的扩展，ASC 可能在加速市场发展方面发挥关键作用。

比最大的地区

预计亚太地区将在预测期内占据最大的市场份额。快速的都市化和医疗基础设施的扩张正在推动该地区手术数量的成长。中国、印度和日本等国正在投资整形外科器械的国内生产和技术进步。政府正在主导促进自给自足，减少对进口的依赖。机器人辅助手术和人工智慧诊断在领先医院的应用正在蓬勃发展。全球和本地公司之间的策略合作伙伴关係正在推动市场渗透和技术创新。

复合年增长率最高的地区：

预计北美将在预测期内实现最高的复合年增长率。该地区在手术机器人、智慧手术室和人工智慧整形外科诊断领域处于领先地位。监管机构正在简化下一代植入的核准途径，加速其商业化进程。医院正在利用数据分析和物联网来优化手术工作流程和植入的使用率。强大的报销框架和微创技术的广泛应用支撑着市场扩张。在精准医疗的推动下，北美持续引领整形外科创新的标竿。

免费客製化服务：

此报告的订阅者可以选择以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球整形外科植入市场（依产品类型）

  • 重组关节重建
    • 髋关节植入
    • 肩关节关节移植
    • 膝关节植入
  • 脊椎移植
    • 核融合装置
    • 非融合装置
  • 人工植牙
  • 创伤植入
  • 生物性骨材
  • 颅颚颜面植入
  • 其他产品类型

6. 全球整形外科植入市场（依生物材料）

  • 金属生物材料
  • 陶瓷生物材料
  • 天然生物材料
  • 聚合物生物材料

7. 全球整形外科植入市场（依手术类型）

  • 开放性手术
  • 机器人辅助手术
  • 微创手术（MIS）

8. 全球整形外科植入市场（依设备类型）

  • 内固定装置
    • 盘子
    • 指甲
    • 拧紧
  • 外固定装置
    • 框架
    • 别针

9. 全球整形外科植入市场（依最终用户）

  • 医院
  • 居家照护环境
  • 整形外科诊所
  • 门诊手术中心
  • 其他最终用户

第 10 章全球整形外科植入市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Stryker Corporation
  • Orthofix Medical Inc.
  • Zimmer Biomet Holdings, Inc.
  • Wright Medical Group NV
  • Smith & Nephew plc
  • BioTek Instruments
  • Johnson & Johnson
  • Exactech, Inc.
  • Medtronic plc
  • B. Braun Melsungen AG
  • Arthrex, Inc.
  • Globus Medical, Inc.
  • CONMED Corporation
  • DJO Global
  • NuVasive, Inc.
Product Code: SMRC31412

According to Stratistics MRC, the Global Orthopedic Implants Market is accounted for $55.92 billion in 2025 and is expected to reach $86.33 billion by 2032 growing at a CAGR of 6.4% during the forecast period. Orthopedic implants are medical devices designed to aid in bone and joint repair by replacing, stabilizing, or reinforcing injured skeletal structures. Typically manufactured from durable, biocompatible materials like titanium, stainless steel, or ceramics, these implants ensure safety within the human body. They are frequently applied in orthopedic surgeries to address fractures, arthritis, or degenerative bone problems. By restoring structural integrity and movement, they significantly alleviate discomfort and enhance the patient's functional health and well-being.

According to data by the World Health Organization (WHO) 2022, 1.71 billion people have musculoskeletal conditions, including low back pain, neck pain, fractures, other injuries, osteoarthritis, amputation, and rheumatoid arthritis.

Market Dynamics:

Driver:

Increasing geriatric population

Conditions such as osteoporosis, arthritis, and joint degeneration are becoming more prevalent among seniors, necessitating surgical interventions. Healthcare systems are increasingly adopting advanced implant technologies to improve mobility and quality of life for aging patients. Minimally invasive orthopedic procedures are gaining traction, reducing recovery time and hospital stays. Innovations in implant design and biomaterials are enhancing compatibility and long-term outcomes. As life expectancy rises globally, the orthopedic implants market is poised for sustained expansion.

Restraint:

Dearth of skilled orthopedic surgeons

A shortage of trained orthopedic surgeons is hindering the growth of the orthopedic implants sector. Many regions, especially in developing countries, face a critical gap in specialized surgical expertise. The complexity of implant procedures demands rigorous training and experience, which limits the number of qualified professionals. Regulatory requirements and certification processes further slow the entry of new surgeons into the field. This talent gap can lead to delayed surgeries and suboptimal patient outcomes. Without strategic investment in medical education and training, market growth may be constrained.

Opportunity:

Rise of ambulatory surgical centers (ASCs)

Ambulatory surgical centers are emerging as key drivers of growth in the orthopedic implants market. These facilities offer cost-effective, high-efficiency environments for performing orthopedic procedures outside traditional hospitals. ASCs are increasingly equipped with advanced imaging and surgical technologies, enabling complex implant surgeries with faster patient turnover. Favorable reimbursement policies and shorter recovery times are attracting both patients and providers to these centers. The trend toward outpatient care is accelerating demand for portable and modular implant systems. As healthcare decentralizes, ASCs are becoming vital hubs for orthopedic innovation and service delivery.

Threat:

Pricing pressures and reimbursement issues

Governments and insurers are tightening cost controls, putting pressure on manufacturers to reduce prices. Reimbursement delays and policy shifts can disrupt cash flow and hinder product adoption. High development and compliance costs make it difficult for companies to maintain profitability under these conditions. Smaller firms are particularly vulnerable to pricing volatility and reimbursement uncertainty. These financial pressures may slow innovation and limit access to advanced implant technologies.

Covid-19 Impact:

The COVID-19 pandemic disrupted orthopedic implant procedures by postponing elective surgeries and straining hospital resources. Lockdowns and supply chain interruptions led to shortages in implant components and surgical tools. However, the crisis accelerated digital adoption, with remote consultations and tele-rehabilitation gaining popularity. Regulatory bodies introduced fast-track approvals to ensure continued access to essential orthopedic devices. Post-pandemic strategies now emphasize resilience, automation, and localized manufacturing to mitigate future disruptions. The market is adapting with renewed focus on flexibility and digital integration across the orthopedic care continuum.

The metallic biomaterialssegment is expected to be the largest during the forecast period

The metallic biomaterials segment is expected to account for the largest market share during the forecast period. These materials, including titanium and stainless steel, offer superior strength, biocompatibility, and durability for load-bearing applications. Their widespread use in joint replacements, spinal implants, and trauma fixation devices underpins their market leadership. Continuous advancements in surface coatings and alloy compositions are improving integration with bone tissue. Hospitals and surgical centers prefer metallic implants for their reliability and long-term performance. As demand for orthopedic procedures rises, metallic biomaterials will remain the cornerstone of implant innovation.

The ambulatory surgical centerssegment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ambulatory surgical centerssegment is predicted to witness the highest growth rate. Their ability to deliver high-quality care at lower costs is reshaping the surgical landscape. ASCs are increasingly performing joint replacements and fracture repairs using advanced implant systems. Enhanced operational efficiency and favorable insurance coverage are driving patient preference for these facilities. Integration of digital inventory and cloud-based monitoring is streamlining implant management. As outpatient orthopedic care expands, ASCs will play a pivotal role in market acceleration.

Region with largest share:

During the forecast period, the Asia Pacificregion is expected to hold the largest market share. Rapid urbanization and expanding healthcare infrastructure are fueling surgical volumes across the region. Countries like China, India, and Japan are investing in domestic production and technological upgrades for orthopedic devices. Government initiatives are promoting self-sufficiency and reducing reliance on imports. Adoption of robotic-assisted surgeries and AI diagnostics is gaining momentum in major hospitals. Strategic collaborations between global and local players are enhancing market penetration and innovation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR. The region leads in surgical robotics, smart operating rooms, and AI-powered diagnostics for orthopedic care. Regulatory agencies are streamlining approval pathways for next-generation implants, accelerating commercialization. Hospitals are leveraging data analytics and IoT to optimize surgical workflows and implant utilization. Strong reimbursement frameworks and high adoption of minimally invasive techniques are supporting market expansion. As precision medicine advances, North America continues to set the benchmark for orthopedic innovation.

Key players in the market

Some of the key players in Orthopedic Implants Market include Stryker Corporation, Orthofix Medical Inc., Zimmer Biomet Holdings, Inc., Wright Medical Group N.V., Smith & Nephew plc, BioTek Instruments, Johnson & Johnson, Exactech, Inc., Medtronic plc, B. Braun Melsungen AG, Arthrex, Inc., Globus Medical, Inc., CONMED Corporation, DJO Global, and NuVasive, Inc.

Key Developments:

In June 2025, Orthofix Medical Inc. announced the global commercial launch of the TrueLok(TM) Elevate Transverse Bone Transport (TBT) System. TrueLok Elevate represents the first commercially available device in the U.S. with a patented design for use in the TBT procedure to provide a limb preservation treatment option for addressing bony or soft tissue deformities or defects, such as diabetic ulcers.

In February 2025, Stryker announced that it has completed the acquisition of Inari Medical, Inc., a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs. The addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing VTE segment.

Product Types Covered:

  • Reconstructive Joint Replacements
  • Spinal Implants
  • Dental Implants
  • Trauma Implants
  • Orthobiologics
  • Craniomaxillofacial Implants
  • Other Product Types

Biomaterials Covered:

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials
  • Polymeric Biomaterials

Procedures Covered:

  • Open Surgery
  • Robotic-Assisted Surgery
  • Minimally Invasive Surgery (MIS)

Device Types Covered:

  • Internal Fixation Devices
  • External Fixation Devices

End Users Covered:

  • Hospitals
  • Home Care Settings
  • Orthopedic Clinics
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.90 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Orthopedic Implants Market, By Product Type

  • 5.1 Introduction
  • 5.2 Reconstructive Joint Replacements
    • 5.2.1 Hip Implants
    • 5.2.2 Shoulder Implants
    • 5.2.3 Knee Implants
  • 5.3 Spinal Implants
    • 5.3.1 Fusion Devices
    • 5.3.2 Non-fusion Devices
  • 5.4 Dental Implants
  • 5.5 Trauma Implants
  • 5.6 Orthobiologics
  • 5.7 Craniomaxillofacial Implants
  • 5.8 Other Product Types

6 Global Orthopedic Implants Market, By Biomaterial

  • 6.1 Introduction
  • 6.2 Metallic Biomaterials
  • 6.3 Ceramic Biomaterials
  • 6.4 Natural Biomaterials
  • 6.5 Polymeric Biomaterials

7 Global Orthopedic Implants Market, By Procedure

  • 7.1 Introduction
  • 7.2 Open Surgery
  • 7.3 Robotic-Assisted Surgery
  • 7.4 Minimally Invasive Surgery (MIS)

8 Global Orthopedic Implants Market, By Device Type

  • 8.1 Introduction
  • 8.2 Internal Fixation Devices
    • 8.2.1 Plates
    • 8.2.2 Nails
    • 8.2.3 Screws
  • 8.3 External Fixation Devices
    • 8.3.1 Frames
    • 8.3.2 Pins

9 Global Orthopedic Implants Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Home Care Settings
  • 9.4 Orthopedic Clinics
  • 9.5 Ambulatory Surgical Centers
  • 9.6 Other End Users

10 Global Orthopedic Implants Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Stryker Corporation
  • 12.2 Orthofix Medical Inc.
  • 12.3 Zimmer Biomet Holdings, Inc.
  • 12.4 Wright Medical Group N.V.
  • 12.5 Smith & Nephew plc
  • 12.6 BioTek Instruments
  • 12.7 Johnson & Johnson
  • 12.8 Exactech, Inc.
  • 12.9 Medtronic plc
  • 12.10 B. Braun Melsungen AG
  • 12.11 Arthrex, Inc.
  • 12.12 Globus Medical, Inc.
  • 12.13 CONMED Corporation
  • 12.14 DJO Global
  • 12.15 NuVasive, Inc.

List of Tables

  • Table 1 Global Orthopedic Implants Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Orthopedic Implants Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Orthopedic Implants Market Outlook, By Reconstructive Joint Replacements (2024-2032) ($MN)
  • Table 4 Global Orthopedic Implants Market Outlook, By Hip Implants (2024-2032) ($MN)
  • Table 5 Global Orthopedic Implants Market Outlook, By Shoulder Implants (2024-2032) ($MN)
  • Table 6 Global Orthopedic Implants Market Outlook, By Knee Implants (2024-2032) ($MN)
  • Table 7 Global Orthopedic Implants Market Outlook, By Spinal Implants (2024-2032) ($MN)
  • Table 8 Global Orthopedic Implants Market Outlook, By Fusion Devices (2024-2032) ($MN)
  • Table 9 Global Orthopedic Implants Market Outlook, By Non-fusion Devices (2024-2032) ($MN)
  • Table 10 Global Orthopedic Implants Market Outlook, By Dental Implants (2024-2032) ($MN)
  • Table 11 Global Orthopedic Implants Market Outlook, By Trauma Implants (2024-2032) ($MN)
  • Table 12 Global Orthopedic Implants Market Outlook, By Orthobiologics (2024-2032) ($MN)
  • Table 13 Global Orthopedic Implants Market Outlook, By Craniomaxillofacial Implants (2024-2032) ($MN)
  • Table 14 Global Orthopedic Implants Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 15 Global Orthopedic Implants Market Outlook, By Biomaterial (2024-2032) ($MN)
  • Table 16 Global Orthopedic Implants Market Outlook, By Metallic Biomaterials (2024-2032) ($MN)
  • Table 17 Global Orthopedic Implants Market Outlook, By Ceramic Biomaterials (2024-2032) ($MN)
  • Table 18 Global Orthopedic Implants Market Outlook, By Natural Biomaterials (2024-2032) ($MN)
  • Table 19 Global Orthopedic Implants Market Outlook, By Polymeric Biomaterials (2024-2032) ($MN)
  • Table 20 Global Orthopedic Implants Market Outlook, By Procedure (2024-2032) ($MN)
  • Table 21 Global Orthopedic Implants Market Outlook, By Open Surgery (2024-2032) ($MN)
  • Table 22 Global Orthopedic Implants Market Outlook, By Robotic-Assisted Surgery (2024-2032) ($MN)
  • Table 23 Global Orthopedic Implants Market Outlook, By Minimally Invasive Surgery (MIS) (2024-2032) ($MN)
  • Table 24 Global Orthopedic Implants Market Outlook, By Device Type (2024-2032) ($MN)
  • Table 25 Global Orthopedic Implants Market Outlook, By Internal Fixation Devices (2024-2032) ($MN)
  • Table 26 Global Orthopedic Implants Market Outlook, By Plates (2024-2032) ($MN)
  • Table 27 Global Orthopedic Implants Market Outlook, By Nails (2024-2032) ($MN)
  • Table 28 Global Orthopedic Implants Market Outlook, By Screws (2024-2032) ($MN)
  • Table 29 Global Orthopedic Implants Market Outlook, By External Fixation Devices (2024-2032) ($MN)
  • Table 30 Global Orthopedic Implants Market Outlook, By Frames (2024-2032) ($MN)
  • Table 31 Global Orthopedic Implants Market Outlook, By Pins (2024-2032) ($MN)
  • Table 32 Global Orthopedic Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 33 Global Orthopedic Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 34 Global Orthopedic Implants Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 35 Global Orthopedic Implants Market Outlook, By Orthopedic Clinics (2024-2032) ($MN)
  • Table 36 Global Orthopedic Implants Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 37 Global Orthopedic Implants Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.